Richard B Lipton
Albert Einstein College of Medicine
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Richard B Lipton as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 04:01 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05016661 · Extension Study of ABP-20001 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 for Migraine PreventionAEON Biopharma, Inc. · terminated · Migraine · principal investigator
- Ph2NCT04845178 · Investigation of Safety and Efficacy of ABP-450 for Migraine Prevention in AdultsAEON Biopharma, Inc. · completed · Migraine · principal investigator
- Ph3NCT00449540 · Efficacy and Safety of TMS for the Preemptive Treatment of Migraine With AuraNeuralieve · completed · Migraine With Aura · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 04:01 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 4 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- Glucose Regulation and Cognitive Function in Type 2 DiabetesP01AG003949 · NIA · ALBERT EINSTEIN COLLEGE OF MEDICINE · fiscal years 1994 to 2026 · $629,611 awarded in 2026Same name and institution; not confirmed by an ID
- Validation of the Remote Cognitive Aging and Alzheimer’s Disease REsearch (R-CARE) ToolboxR01AG080635 · NIA · ALBERT EINSTEIN COLLEGE OF MEDICINE · fiscal years 2023 to 2026 · $2,254,729 awarded in 2026Same name and institution; not confirmed by an ID
- Einstein Center for Excellence for Clinical Trials in NeuroscienceU10NS077308 · NINDS · ALBERT EINSTEIN COLLEGE OF MEDICINE · fiscal years 2011 to 2017 · $1,608 awarded in 2017Same name and institution; not confirmed by an ID
- PHENOTYPE & GENOTYPE FOR EXEPTIONAL LONGEVITY & THE PREVENTION OF COGNITIVE DECLIP01AG027734 · NIA · ALBERT EINSTEIN COLLEGE OF MEDICINE · fiscal years 2007 to 2012 · $19,046 awarded in 2012Same name and institution; not confirmed by an ID
- AGING1M01RR012248 · NCRR · ALBERT EINSTEIN COLLEGE OF MEDICINE · fiscal years 2004 to 2008 · $101,037 awarded in 2008Same name and institution; not confirmed by an ID
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 04:01 UTC. The ranking covers the 200 most relevant of 160 PubMed records, and a shared surname and initials can bring in a namesake. All 160 on PubMed
- OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial.Cephalalgia · 2010711 citationsRCR 27.6
- 683 citationsRCR 26.5
- OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial.Cephalalgia · 2010665 citationsRCR 25.7
- Prevalence of frequent headache in a population sample.Headache · 1998451 citationsRCR 17.9
- 441 citationsRCR 15.2
- Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.Headache · 2007382 citationsRCR 13.2
- 380 citationsRCR 16.0
- 367 citationsRCR 12.7
- Gait dysfunction in mild cognitive impairment syndromes.J Am Geriatr Soc · 2008321 citationsRCR 11.1
- Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial.Lancet Neurol · 2010296 citationsRCR 10.6